Arrowhead Pharmaceuticals (ARWR) had the highest return in January 2004 by a mid-cap US stock or mid-cap US stock, returning 259%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Arrowhead Pharmaceuticals (ARWR) | January 2004 | 258.97% |
Camtek (CAMT) | January 2004 | 80.66% |
ASGN (ASGN) | January 2004 | 44.19% |
Viavi Solutions (VIAV) | January 2004 | 38.96% |
Chemed (CHE) | January 2004 | 36.63% |
Tutor Perini (TPC) | January 2004 | 36.32% |
Cavco Industries (CVCO) | January 2004 | 34.79% |
Onto Innovation (ONTO) | January 2004 | 34.63% |
Terawulf (WULF) | January 2004 | 32.17% |
Open Text (OTEX) | January 2004 | 31.54% |
Century Aluminum (CENX) | January 2004 | 31.54% |
Riot Blockchain (RIOT) | January 2004 | 30.43% |
Plug Power (PLUG) | January 2004 | 30.21% |
BlackBerry (BB) | January 2004 | 29.57% |
RadNet (RDNT) | January 2004 | 29.09% |
Vera Therapeutics (VERA) | January 2004 | 27.27% |
Amdocs (DOX) | January 2004 | 27.22% |
Enpro Industries (NPO) | January 2004 | 26.9% |
Synaptics (SYNA) | January 2004 | 25.87% |
Plexus (PLXS) | January 2004 | 24.76% |
Bruker (BRKR) | January 2004 | 23.06% |
United States Lime & Minerals (USLM) | January 2004 | 22.29% |
ViaSat (VSAT) | January 2004 | 21.93% |
Pilgrims Pride (PPC) | January 2004 | 21.91% |
Affiliated Managers (AMG) | January 2004 | 21.58% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
